ChemoCentryx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ChemoCentryx and buy or sell other stocks, ETFs, and their options commission-free!

About CCXI

ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. 

CEO
David M. Reese, MD
CEODavid M. Reese, MD
Employees
Employees
Headquarters
San Carlos, California
HeadquartersSan Carlos, California
Founded
1996
Founded1996
Employees
Employees

CCXI Key Statistics

Market cap
3.71B
Market cap3.71B
Price-Earnings ratio
-27.56
Price-Earnings ratio-27.56
Dividend yield
Dividend yield
Average volume
864.70K
Average volume864.70K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$52.00
52 Week high$52.00
52 Week low
$14.95
52 Week low$14.95

People also own

Based on the portfolios of people who own CCXI. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.